SIDE LETTER AGREEMENT

[// GUIDANCE: A side letter grants specific rights to an investor that are not included in the main transaction documents. Side letters are common in venture capital financings and may include provisions such as most favored nations (MFN) clauses, enhanced information rights, co-investment rights, or board observer rights. Be cautious about granting side letter rights that conflict with or undermine the main agreements.]

---

SIDE LETTER AGREEMENT

This Side Letter Agreement (this "Side Letter") is entered into as of [DATE] (the "Effective Date"), by and between:

Company:
[COMPANY NAME], a Delaware corporation (the "Company")

and

Investor:
[INVESTOR NAME] (the "Investor")

---

RECITALS

A. The Company and the Investor are parties to that certain Series [A] Preferred Stock Purchase Agreement dated [DATE] (the "Purchase Agreement").

B. The Company and the Investor are also parties to that certain Investors' Rights Agreement dated [DATE] (the "IRA"), that certain Voting Agreement dated [DATE] (the "VA"), and that certain Right of First Refusal and Co-Sale Agreement dated [DATE] (the "ROFR Agreement," and together with the IRA and VA, the "Transaction Documents").

C. In connection with the Investor's investment in the Company, the Company has agreed to provide the Investor with certain additional rights as set forth in this Side Letter.

NOW, THEREFORE, in consideration of the mutual promises and covenants set forth herein, the parties agree as follows:

---

ARTICLE 1 - ADDITIONAL RIGHTS

[// GUIDANCE: Select and customize the provisions that apply to this investor. Delete sections that do not apply.]

1.1 Most Favored Nation (MFN)

[// GUIDANCE: MFN provisions allow this investor to receive any more favorable terms granted to other investors.]

☐ MFN Provision Included:

(a) If the Company enters into any side letter or similar agreement with any other investor in connection with such investor's purchase of securities of the Company that provides such investor with rights or terms more favorable than those provided to the Investor under this Side Letter or the Transaction Documents, the Company shall promptly notify the Investor of such rights or terms.

(b) Upon written request by the Investor, the Company shall amend this Side Letter or the applicable Transaction Document to provide the Investor with such more favorable rights or terms.

(c) This MFN provision shall apply to:
☐ All investors in the current financing round
☐ All investors in the current and subsequent financing rounds
☐ Investors purchasing at least $[THRESHOLD] of securities

1.2 Enhanced Information Rights

☐ Enhanced Information Rights Included:

In addition to the information rights provided under the IRA, the Investor shall receive:

(a) Weekly/Bi-Weekly Reports: [FREQUENCY] reports on key operating metrics, including [SPECIFY METRICS];

(b) Board Meeting Materials: Copies of all materials provided to the Board of Directors, to be provided at the same time as directors receive such materials;

(c) Cap Table Updates: Updated capitalization table within [5] business days of any change;

(d) Material Contracts: Copies of all material contracts entered into by the Company;

(e) Litigation Updates: Prompt notice of any material litigation or regulatory proceedings;

(f) Other: [SPECIFY].

1.3 Board Observer Rights

☐ Board Observer Rights Included:

(a) For so long as the Investor holds at least [THRESHOLD] shares of the Company's capital stock, the Investor shall have the right to designate one representative to attend all meetings of the Board of Directors as a non-voting observer.

(b) The observer shall receive:
- Notice of all Board meetings at the same time as directors;
- Copies of all Board materials;
- The right to attend meetings in person or remotely.

(c) The observer may be excluded from portions of meetings involving conflicts of interest, attorney-client privilege, or competitive harm.

1.4 Co-Investment Rights

☐ Co-Investment Rights Included:

(a) The Company shall provide the Investor with the opportunity to co-invest alongside the Company's lead investors in future financing rounds, subject to the following terms:

(b) Allocation: The Investor shall have the right to invest up to $[AMOUNT] (or [XX]% of the total round) in each future financing round, subject to allocation by the lead investor(s).

(c) Terms: The Investor's co-investment shall be on the same terms as the lead investor(s).

(d) Notice: The Company shall provide the Investor with at least [10] business days' notice of any co-investment opportunity.

1.5 Anti-Dilution Top-Up Rights

☐ Anti-Dilution Top-Up Rights Included:

If the Company issues additional securities at a price per share lower than the Investor's purchase price (a "Down Round"), the Investor shall have the right (but not the obligation) to purchase additional shares at the Down Round price sufficient to maintain the Investor's percentage ownership on a fully-diluted basis, subject to:

(a) The Investor exercising such right within [30] days of notice of the Down Round;

(b) The Investor purchasing at least $[MINIMUM AMOUNT] of additional securities.

1.6 Preemptive Rights Enhancement

☐ Enhanced Preemptive Rights Included:

(a) Notwithstanding the pro rata rights threshold in the IRA, the Investor shall be entitled to participate in any future issuance of equity securities regardless of the number of shares held.

(b) The Investor's pro rata right shall be calculated based on [fully-diluted / outstanding] capitalization.

(c) The Investor shall have the right to purchase [up to 2x] its pro rata share if other investors do not fully exercise their pro rata rights.

1.7 Liquidity Rights

☐ Liquidity Rights Included:

(a) Secondary Sale Right: Upon request by the Investor, the Company shall use commercially reasonable efforts to facilitate the Investor's sale of shares in a secondary transaction, provided such sale would not adversely affect the Company.

(b) IPO Registration Priority: In connection with an IPO, the Investor shall be entitled to include [XX]% of its shares in any underwriter cutback before other investors.

1.8 Founder Lock-Up

☐ Founder Lock-Up Included:

(a) The founders listed on Exhibit A shall not sell, transfer, or otherwise dispose of any shares of the Company's capital stock for a period of [12-24] months following the Effective Date without the prior written consent of the Investor.

(b) This lock-up is in addition to any lock-up provisions in the Transaction Documents.

1.9 Key Person Provision

☐ Key Person Provision Included:

(a) For so long as the Investor holds shares of the Company's capital stock, [FOUNDER NAME(S)] (the "Key Persons") shall devote substantially all of their professional time and attention to the Company's business.

(b) If any Key Person ceases to be employed by or provide services to the Company for any reason, the Company shall promptly notify the Investor.

1.10 Exclusivity/Non-Compete

☐ Exclusivity Provision Included:

(a) For a period of [12-24] months following the Effective Date, the Company shall not enter into any financing transaction with [COMPETITOR NAME(S)] or their affiliates without the prior written consent of the Investor.

1.11 Advisory Board Seat

☐ Advisory Board Seat Included:

The Investor shall have the right to designate one representative to serve on the Company's advisory board (if one exists or is created).

1.12 Expense Reimbursement

☐ Expense Reimbursement Included:

The Company shall reimburse the Investor for reasonable legal fees and out-of-pocket expenses incurred in connection with this investment, up to a maximum of $[AMOUNT].

---

ARTICLE 2 - REPRESENTATIONS AND WARRANTIES

2.1 Company Representations

The Company represents and warrants that:

(a) The execution and delivery of this Side Letter has been duly authorized by all necessary corporate action;

(b) This Side Letter constitutes the legal, valid, and binding obligation of the Company;

(c) The execution of this Side Letter does not conflict with any agreement to which the Company is a party.

2.2 No Conflict with Transaction Documents

The parties acknowledge that this Side Letter is supplemental to the Transaction Documents. In the event of any conflict between this Side Letter and the Transaction Documents, the terms of this Side Letter shall control with respect to the Investor only.

---

ARTICLE 3 - CONFIDENTIALITY

3.1 Confidential Treatment

The existence and terms of this Side Letter shall be treated as confidential by both parties, except:

(a) As required by law or legal process;

(b) To the extent the Company is required to disclose the existence of this Side Letter to other investors pursuant to MFN provisions in other agreements;

(c) To the parties' respective legal, financial, and tax advisors;

(d) To the Investor's limited partners and investors, subject to confidentiality obligations.

3.2 Disclosure to Other Investors

[// GUIDANCE: Transparency about side letters can help avoid disputes.]

☐ The Company shall disclose the existence (but not necessarily the specific terms) of this Side Letter to other investors in the current financing round.

☐ The Company may disclose the terms of this Side Letter to other investors who have MFN rights.

---

ARTICLE 4 - GENERAL PROVISIONS

4.1 Term

This Side Letter shall remain in effect until the earliest of:

(a) The closing of the Company's initial public offering;

(b) The Investor ceasing to hold any shares of the Company's capital stock;

(c) A merger, consolidation, or sale of substantially all of the Company's assets in which the stockholders receive cash or publicly traded securities;

(d) The written agreement of the parties to terminate this Side Letter.

4.2 Assignment

The Investor may assign its rights under this Side Letter to:

(a) Any affiliate of the Investor;

(b) Any transferee who acquires all or substantially all of the Investor's shares of the Company's capital stock;

provided that such transferee agrees in writing to be bound by the terms of this Side Letter.

4.3 Amendment

This Side Letter may be amended only by a written instrument signed by both parties.

4.4 Governing Law

This Side Letter shall be governed by and construed in accordance with the laws of the State of Delaware, without regard to conflict of laws principles.

4.5 Jurisdiction

Each party irrevocably submits to the exclusive jurisdiction of the Court of Chancery of the State of Delaware (or, if such court lacks jurisdiction, any state or federal court in Delaware) for any action arising out of or relating to this Side Letter.

4.6 Entire Agreement

This Side Letter, together with the Transaction Documents, constitutes the entire agreement between the parties with respect to the subject matter hereof.

4.7 Counterparts

This Side Letter may be executed in counterparts. Electronic signatures shall be deemed original signatures.

4.8 Notices

All notices shall be in writing and delivered to the addresses set forth below (or such other addresses as may be designated in writing):

If to the Company:
[COMPANY NAME]
[ADDRESS]
[CITY, STATE ZIP]
Attention: [OFFICER]
Email: [EMAIL]

If to the Investor:
[INVESTOR NAME]
[ADDRESS]
[CITY, STATE ZIP]
Attention: [CONTACT]
Email: [EMAIL]

---

EXECUTION

IN WITNESS WHEREOF, the parties have executed this Side Letter Agreement as of the Effective Date.

COMPANY:

[COMPANY NAME]

By: _________________________________

Name: [AUTHORIZED SIGNATORY NAME]

Title: [TITLE]

Date: _________________________________

---

INVESTOR:

[INVESTOR NAME]

By: _________________________________

Name: [AUTHORIZED SIGNATORY NAME]

Title: [TITLE]

Date: _________________________________

---

EXHIBIT A - FOUNDERS SUBJECT TO LOCK-UP (IF APPLICABLE)

Founder Name	Number of Shares	Lock-Up Period
[NAME]	[SHARES]	[PERIOD]
[NAME]	[SHARES]	[PERIOD]

---

This Side Letter Agreement grants specific additional rights to an investor in connection with a venture capital financing. Side letters should be carefully reviewed to ensure they do not conflict with the main transaction documents or create obligations the company cannot fulfill. This document should be reviewed by qualified legal counsel before execution.